3 Top Biotech Stocks to Buy for the Long Haul

3 Top Biotech Stocks to Buy for the Long Haul
·5 min read

The United Nations anticipates that the global population over the age of 65 is expected to surge from 727 million people in 2020 to over 1.5 billion people by 2050. Long-term investors should consider purchasing Amgen (NASDAQ: AMGN). There are 20 molecules currently in phase 1 clinical trials and 19 molecules in phase 2 or 3 clinical trials.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting